highperformr logo

Antengene's Overview

Total employees67
HeadquartersShanghai
Founded2017

Antengene Corporation (SEHK: 6996.HK) is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicine. They are committed to an 'combo-only' R&D strategy and building a pipeline of 13 clinical assets, including 8 global rights assets and 5 assets with rights for Asia Pacific markets including Mainland China, Australia, South Korea and certain Southeast Asian countries. Their vision is to treat patients beyond borders and help them live longer, healthier lives by developing and commercializing first-in-class/best-in-class oncology therapies.

Where is Antengene's Headquarters?

HQ Function

Serves as the central hub for strategic decision-making, research and development coordination, corporate governance, and global operational management.

Notable Features:

Located in a modern business park, Vanke Centre, likely featuring contemporary office spaces designed to foster collaboration and innovation among its research, clinical, and corporate teams.

Work Culture:

Emphasizes scientific rigor, innovation, collaboration, and a patient-first approach. The culture likely supports dynamic R&D efforts and cross-functional teamwork required in the biopharmaceutical industry.

HQ Significance:

Shanghai is a major and rapidly growing hub for biotechnology and pharmaceutical innovation in China and globally, providing access to talent, research institutions, and investment opportunities.

Values Reflected in HQ: The choice of a modern facility in a key biotech hub reflects Antengene's commitment to innovation, growth, and its position at the forefront of oncological research.

Location:

Antengene Corporation has established a significant presence across the Asia-Pacific region and is expanding globally. Key functions supported globally include clinical research and development, regulatory affairs, manufacturing liaison, business development, and commercial operations. Their primary focus markets are Mainland China, Australia, South Korea, Taiwan, Hong Kong, and ASEAN countries.

Street Address:

15F, Block B, Vanke Centre, No. 700 Shenchang Road

City:

Shanghai

State/Province:

Shanghai

Country:

China

Antengene's Global Presence

Hong Kong, China

Address: Unit 702, 7/F, Lee Garden Two, 28 Yun Ping Road, Causeway Bay, Hong Kong

Supports corporate finance, investor relations, and strategic partnerships within the Greater China region and internationally.

Singapore, Singapore

Address: 1 Fusionopolis Place, #03-20 Galaxis (West Lobby), Singapore 138522

To advance Antengene's pipeline and commercialize approved therapies within Singapore and the broader ASEAN region.

Seoul, South Korea

Address: Antengene Korea Ltd., #1001, 10F, Signature Towers Seoul (East), 100 Cheonggyecheon-ro, Jung-gu, Seoul, Republic of Korea

Focuses on local clinical development, patient access programs, and market entry strategies for South Korea.

Melbourne, VIC, Australia

Address: Antengene Australia Pty Ltd., Suite 2, Level 10, 3 Bowen Crescent, Melbourne VIC 3004, Australia

Facilitates clinical research and development activities in the Oceania region, contributing to global drug development programs.

Buying Intent Signals for Antengene

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Antengene

As of April 2025, Antengene' leadership includes:

Jay Mei, M.D., Ph.D. - Founder, Chairman and Chief Executive Officer
John Q. Chi, CPA, CMA - Chief Financial Officer
Kevin Lynch, M.D. - Chief Medical Officer
Thomas Karalis - Head of Asia Pacific Commercial
Brian A. Campbell - Chief Business Officer
Zhiyong Du, Ph.D. - Chief Strategy Officer

Investors of Antengene

Antengene has been backed by several prominent investors over the years, including:

Fidelity Management & Research Company
BlackRock
GIC Private Limited (Singapore's Sovereign Wealth Fund)
Boyu Capital
FountainVest Partners
Laurion Capital Management
Celgene (now Bristol Myers Squibb, via collaboration)
WuXi AppTec (through corporate venture fund)
Hillhouse Capital
Ally Bridge Group

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

Antengene has actively strengthened its executive team with key appointments over the past year to support its growth and strategic objectives in the oncology sector.

New Appointments:

Brian A. Campbell, Brian A. Campbell appointed as Chief Business Officer to lead global business development, corporate strategy, and commercial planning. He brings extensive experience from previous roles at BeiGene and Merck.

Technology (Tech Stack) used by Antengene

Discover the tools Antengene uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Antengene Email Formats and Examples

Antengene Corporation likely utilizes a standard professional email format, commonly combining the employee's first initial and last name, or full first name and last name, with their company domain.

[firstinitial][lastname]@antengene.com or [firstname].[lastname]@antengene.com

Format

jmei@antengene.com

Example

85%

Success rate

News and media

Antengene Press Release / PR NewswireJuly 8, 2024

Antengene Announces NDAs for Selinexor in Multiple Myeloma Accepted for Review in Thailand and Malaysia

Antengene Corporation announced that the New Drug Applications (NDAs) for selinexor (XPOVIO®) in combination with dexamethasone for the treatment of adult patients with relapsed and/or refractory multiple myeloma have been accepted for review by regulatory authorities in Thailand and Malaysia....more

Antengene Press Release / PR NewswireMay 27, 2024

Antengene Announces ATG-018 Phase I Study Achieves First Patient Dosed in Australia

Antengene announced that the first patient has been dosed in the Phase I 'ATOM' trial of ATG-018, a small molecule ATR inhibitor, in patients with advanced solid tumors and hematological malignancies in Australia....more

Antengene Press Release / PR NewswireJanuary 29, 2024

Antengene Announces Appointment of Mr. Brian A. Campbell as Chief Business Officer

Antengene Corporation Limited announced the appointment of Mr. Brian A. Campbell as Chief Business Officer (CBO), effective January 29, 2024. Mr. Campbell will be responsible for global business development, corporate strategy, and commercial planning....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Antengene, are just a search away.